Korean firm builds sales force to PHL beauty-market share (Business Mirror (Philippines))

DAEWOONG Pharmaceutical Co. Ltd.’s technology, through its latest neurotoxin drug Nabota, is expecting to double its target share of the Philippine aesthetic market by next year on the back of a strong local sales force. Nabota Philippines Brand Manager Christopher Cachuela told the BusinessMirror they are on track to meet their 2015 goal of 15 percent…

You may also like...